3-(1-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL)BENZOIC ACID, 95.0%, 250mg

2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine hydrochloride, 95.0%, 500g

N,N-Diethyl-1,4-cyclohexanediamine (cis- and trans- mixture)>95.0%(GC)5g

N-(2-fluorophenyl)-3-oxobutanamide, 95.0%, 1g

Ethyl 6,8-dichloroimidazo[1,2-b]pyridazine-3-carboxylate, 97%, 250mg

1,3,5-Triethynylbenzene>98.0%(GC)5g

(R)-N-Boc-3-Morpholinecarbaldehyde, 95.0%, 5g

1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 97%, 1g

4-Chloroisatoic Anhydride>98.0%(HPLC)(T)1g

2-Chloro-N-cyclopentylacetamide, 95.0%, 1g

tert-Butyl 12-Hydroxy-4,7,10-trioxadodecanoate>97.0%(GC)5g

2-Chloro-6-(trifluoromethyl)pyridin-4-amine, 95.0%, 100mg

6-Methylchromone-3-carbonitrile>98.0%(HPLC)(N)5g